Polymorphism at the mucin-like protocadherin gene influences susceptibility to gallstone disease

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2089-2093

  Chuang, Shih Chang ^a,b   Hsi, Edward ^a,b   Wang, Shen Nien ^a,b   Yu, Ming Lung ^a,c   Lee, King Teh ^a,b   Juo, Suh Hang Hank ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

Gallstone disease; Mucin like protocadherin; Single nucleotide polymorphism

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLELITHIASIS; CONTROLLED STUDY; FEMALE; GENDER; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUPCDH GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CADHERINS; CASE-CONTROL STUDIES; FEMALE; GALLSTONES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUCINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80053641605     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.07.015     Document Type: Article

References (45)

1. Lammert F., Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005, 2:423-433.
2. Lu S.N., Chang W.Y., Wang L.Y., et al. Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol 1990, 12:542-546.
3. Liu C.-M., Tung T.-H., Chou P., et al. Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. World J Gastroenterol 2006, 12:1281-1286.
4. Dowling R.H. Review: pathogenesis of gallstones. Aliment Pharmacol Ther 2000, 14(Suppl 2):39-47.
5. Grünhage F., Lammert F. Pathogenesis of gallstones: a genetic perspective. Best Pract Res Clin Gastroenterol 2006, 20:997-1015.
6. Kosters A., Jirsa M., Groen A.K. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta (BBA)-Mol. Basis Dis. 2003, 1637:1-19.
7. Mittal B., Mittal R.D. Genetics of gallstone disease. J Postgrad Med 2002, 48:149-152.
8. Raffel L.J. The epidemiology and genetic basis of common diseases. Pediatr Ann 1997, 26:525-534.
9. Katsika D., Grjibovski A., Einarsson C., Lammert F., Lichtenstein P., Marschall H.-U. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology (Baltimore, Md) 2005, 41:1138-1143.
10. Goldberg M., Wei M., Yuan L., Murty V.V., Tycko B. Biallelic expression of HRAS and MUCDHL in human and mouse. Hum Genet 2003, 112:334-342.
11. Goldberg M., Wei M., Tycko B., Falikovich I., Warburton D. Identification and expression analysis of the human mu-protocadherin gene in fetal and adult kidneys. Am J Physiol-Renal 2002, 283:F454-F463.
12. Suzuki S.T. Protocadherins and diversity of the cadherin superfamily. J Cell Sci 1996, 109(Pt 11):2609-2611.
13. Angst B.D., Marcozzi C., Magee A.I. The cadherin superfamily: diversity in form and function. J Cell Sci 2001, 114:629-641.
14. Kim H.J., Kim S.H., Chae G.B., Lee S.J., Kang C.D. Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients. Tohoku J Exp Med 2008, 214:139-144.
15. Vilkin A., Nudelman I., Morgenstern S., et al. Gallbladder inflammation is associated with increase in mucin expression and pigmented stone formation. Dig Dis Sci 2007, 52:1613-1620.
16. Finzi L., Barbu V., Burgel P.-R., et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. Am J Pathol 2006, 169:2031-2041.
17. Kim H.J., Kim J.S., Kim K.O., et al. Expression of MUC3, MUC5AC, MUC6 and epidermal growth factor receptor in gallbladder epithelium according to gallstone composition. Korean J Gastroenterol=Taehan Sohwagi Hakhoe Chi 2003, 42:330-336.
18. Lee K.-T., Liu T.-S. Mucin gene expression in gallbladder epithelium. J Formos Med Assoc 2002, 101:762-768.
19. Lee K.T., Liu T.S. Mucin gene expression in gallbladder epithelium with black pigment stone ascertained by in situ hybridization. Kaohsiung J Med Sci 2001, 17:517-523.
20. Chuang S.C., Juo S.H., Hsi E., et al. Multiple mucin genes polymorphisms are associated with gallstone disease in Chinese men. Clin Chim Acta 2011, 412:599-603.
21. Grundy S.M. Cholesterol gallstones: a fellow traveler with metabolic syndrome?. Am J Clin Nutr 2004, 80:1-2.
22. Mendez-Sanchez N., Chavez-Tapia N.C., Motola-Kuba D., et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005, 11:1653-1657.
23. Tzeng J.Y., Wang C.H., Kao J.T., Hsiao C.K. Regression-based association analysis with clustered haplotypes through use of genotypes. Am J Hum Genet 2006, 78:231-242.
24. Buch S., Schafmayer C., Volzke H., et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007, 39:995-999.
25. Wang H.H., Portincasa P., Wang D.Q.H. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci: J Virtual Libr 2008, 13:401-423.
26. Nakamoto K., Wang S., Jenison R.D., et al. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene. BMC Genet 2006, 7:1-12.
27. Srivastava A., Pandey S.N., Dixit M., Choudhuri G., Mittal B. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J Gastroenterol Hepatol 2008, 23:970-975.
28. Kuo K.K., Shin S.J., Chen Z.C., Yang Y.H.C., Yang J.F., Hsiao P.J. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008, 95:1005-1011.
29. Klass D.M., Lauer N., Hay B., Kratzer W., Fuchs M. Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation. Am J Gastroenterol 2007, 102:2482-2487.
30. Miyasaka K., Kanai S., Ohta M., et al. Age-associated gallstone formation in male and female CCK-1(A) receptor-deficient mice. J Gastroenterol 2007, 42:493-496.
31. Sasaki M., Nakanuma Y., Kim Y.S. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 1998, 27:54-61.
32. Zen Y., Harada K., Sasaki M., et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 2002, 161:1475-1484.
33. Paris M.J., Williams B.R. Characterization of a 500-kb contig spanning the region between c-Ha-Ras and MUC2 on chromosome 11p15.5. Genomics 2000, 69:196-202.
34. Afdhal N.H., Ostrow J.D., Koehler R., et al. Interaction of bovine gallbladder mucin and calcium-binding protein: effects on calcium phosphate precipitation. Gastroenterology 1995, 109:1661-1672.
35. Liang C.L., Hsi E., Chen K.C., Pan Y.R., Wang Y.S., Juo S.H. A functional polymorphism at 3' UTR of the PAX6 gene may confer risk for extreme myopia in Chinese. Invest Ophthalmol Vis Sci 2011, 52(6):3500-3505.
36. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
37. Mishra P.J., Humeniuk R., Longo-Sorbello G.S., Banerjee D., Bertino J.R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 2007, 104:13513-13518.
38. Yang H.C., Lin C.H., Hsu C.L., et al. A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci 2006, 13:489-498.
39. Ozaki K., Sato H., Inoue K., et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet 2009, 41:329-333.
40. Acalovschi M., Buzas C., Radu C., Grigorescu M. Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. J Viral Hepat 2009, 16:860-866.
41. Bini E.J., McGready J. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States. Hepatology 2005, 41:1029-1036.
42. Chapman B.A., Wilson I.R., Frampton C.M., et al. Prevalence of gallbladder disease in diabetes mellitus. Dig Dis Sci 1996, 41:2222-2228.
43. Silva M.A., Wong T. Gallstones in chronic liver disease. J Gastrointest Surg 2005, 9:739-746.
44. Boland L.L., Folsom A.R., Rosamond W.D. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: a prospective study. Ann Epidemiol 2002, 12:131-140.
45. Zeggini E., Rayner W., Morris A.P., et al. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat Genet 2005, 37:1320-1322.